Search results for: 'postur push analyst for laboratory develop'
- Related search terms
- development startup and future trend of ophthalmic drugs market
- development states and future trend of ophthalmic drugs market
- development startup ad future trend of ophthalmic drugs market
- forces managed security services market study
- forens managed security services market study
-
11 Aug 2022  |  Global  |  Market Research
Insights for CISOs—Improving Security Posture with CIAM
3 Opportunities for CIAM to Enhance Business Value
IAM systems are designed to identify, authenticate, and authorize identities; enabling approved users and devices to access hardware, software, or other resources. The sub-segments within IAM include access management for workforce, customers, and non-human identities (machines, bots, IoT and other connected devices), identity governance administra...
$2,450.00
Special Price $1,837.50 save 25 %
-
29 Jun 2020  |  Global  |  Technology Research
Future of Software Development: Inching Towards the 'New Stack'
Enabling Best Practices for Future Software Development
Many technologies operate in parallel as a matter of redundancy. Others operate in parallel to facilitate change management and business transformation from an old version to a new version. It is now often said that the transformation from old stack to new stack for software development will be achieved through cloud native microservices architectu...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Jun 2023  |  Global  |  Technology Research
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics
Disruptive Technology Advances in SynBio Foster a Thriving Stakeholder Ecosystem and Accelerate Biopharma Developments
The SynBio field has evolved well over the past two decades, with significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening ...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Oct 2022  |  Global  |  Technology Research
No Code: The Future of Software Development Process
No-code Platforms Will Disrupt the Way Enterprises Develop Their Applications.
As enterprises emerge from the COVID-19 pandemic, many are still struggling to completely resume operations, such as streamlining workflows, improving employee productivity, and enhancing customer experience, in an operating environment that is vastly different from what it was 2 years ago. Enterprises’ teams are more geographically dispersed than ...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Oct 2021  |  North America  |  Market Research
Global Tissue Diagnostics (TDx) Growth Opportunities
Companion Diagnostics (CDx)-specific Advanced Staining and Anatomical Pathology Laboratory Information Systems (APLIS) to Drive Ma
This research service provides an overview of the global TDx market and a 4-year forecast of it from 2021 to 2025. The market will reach $8,848.6 million in 2025, growing at a compound annual growth rate (CAGR) of 8.9% from 2020 to 2025. The advanced staining and anatomical pathology laboratory information management systems (APLIS) segments will g...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Dec 2020  |  North America  |  Market Research
Transition to Hybrid Cloud Services to Trigger the Growth of Laboratory Information Management Systems in the United States and European Union, 2020
Thriving Demand for Biorepositories and Maturity of the Biobanking Industry to Unlock New Growth Opportunities
The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU laboratory information management system (LIMS) industry, highlighting the key growth opportunities, market revenue forecast, and trends that will play an important role in industry growth. The US and EU LIMS market covered in this study is segmented...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 May 2025  |  North America  |  Market Research
Analyst Perspective on Agentic AI
What to Expect in 2025-2027
Although artificial intelligence (AI) has been around for decades, and the contact center industry has been leveraging it for years, recent advancements in AI have rapidly accelerated. The latter half of 2024 spouted industry excitement for next-level GenAI - agentic AI, also sometimes called autonomous AI. Agentic AI can act as the glue for orches...
$2,450.00
Special Price $2,205.00 save 10 %
-
19 Jun 2017  |  Asia Pacific  |  Market Research
Growth Opportunities in the APAC IVD Market, Forecast to 2021
Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market
The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016. Research Scope: • Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions: o Immunochemistry o Self-monitoring Blood Glucose (SMBG) Meter o Hematology o Point-of-care T...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Jun 2021  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities
Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential
This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 May 2024  |  Global  |  Technology Research
Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics)
Rising Popularity Among Tier 1 Pharma Companies and Technological Advances in Drug Delivery Push Biologics Development
There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...
$4,950.00
Special Price $3,712.50 save 25 %